These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36039945)

  • 1. Neuropsychiatric symptoms are associated with exacerbated cognitive impairment in covert cerebral small vessel disease.
    Arola A; Levänen T; Laakso HM; Pitkänen J; Koikkalainen J; Lötjönen J; Korvenoja A; Erkinjuntti T; Melkas S; Jokinen H
    J Int Neuropsychol Soc; 2023 Jun; 29(5):431-438. PubMed ID: 36039945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic associations of cognitive and motor impairments with functional outcome in covert cerebral small vessel disease.
    Jokinen H; Laakso HM; Ahlström M; Arola A; Lempiäinen J; Pitkänen J; Paajanen T; Sikkes SAM; Koikkalainen J; Lötjönen J; Korvenoja A; Erkinjuntti T; Melkas S
    Eur J Neurol; 2022 Jan; 29(1):158-167. PubMed ID: 34528346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective vs informant-reported cognitive complaints have differential clinical significance in covert cerebral small vessel disease.
    Arola A; Laakso HM; Heinonen H; Pitkänen J; Ahlström M; Lempiäinen J; Paajanen T; Virkkala J; Koikkalainen J; Lötjönen J; Korvenoja A; Melkas S; Jokinen H
    Cereb Circ Cogn Behav; 2023; 5():100182. PubMed ID: 37745893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects.
    Kan CN; Gyanwali B; Hilal S; Ng KP; Venketasubramanian N; Chen CL; Xu X
    J Alzheimers Dis; 2020; 73(3):1053-1062. PubMed ID: 31884482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
    Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
    Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
    Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
    Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instrumental Activities of Daily Living, Neuropsychiatric Symptoms, and Neuropsychological Impairment in Mild Cognitive Impairment.
    Ginsberg TB; Powell L; Emrani S; Wasserman V; Higgins S; Chopra A; Cavalieri TA; Libon DJ
    J Am Osteopath Assoc; 2019 Feb; 119(2):96-101. PubMed ID: 30688355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral Perfusion and the Burden of Small Vessel Disease in Patients Referred to a Memory Clinic.
    Onkenhout L; Appelmans N; Kappelle LJ; Koek D; Exalto L; de Bresser J; Biessels GJ;
    Cerebrovasc Dis; 2020; 49(5):481-486. PubMed ID: 33075786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline white matter hyperintensities affect the course of cognitive function after small vessel disease-related stroke: a prospective observational study.
    Fruhwirth V; Enzinger C; Fandler-Höfler S; Kneihsl M; Eppinger S; Ropele S; Schmidt R; Gattringer T; Pinter D
    Eur J Neurol; 2021 Feb; 28(2):401-410. PubMed ID: 33065757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of Small Vessel Disease Biomarkers Reduces the Magnitude of Cognitive Recovery after Ischemic Stroke.
    Sagnier S; Catheline G; Munsch F; Bigourdan A; Poli M; Debruxelles S; Renou P; Olindo S; Rouanet F; Dousset V; Tourdias T; Sibon I
    Cerebrovasc Dis; 2021; 50(4):456-463. PubMed ID: 33827075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural network efficiency predicts cognitive decline in cerebral small vessel disease.
    Boot EM; Mc van Leijsen E; Bergkamp MI; Kessels RPC; Norris DG; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2020; 27():102325. PubMed ID: 32622317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease.
    Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric symptoms as a sign of small vessel disease progression in cognitive impairment.
    Clancy U; Ramirez J; Chappell FM; Doubal FN; Wardlaw JM; Black SE
    Cereb Circ Cogn Behav; 2022; 3():100041. PubMed ID: 36324402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of cognitive reserve and psychological resilience with cognitive functioning in subjects with cerebral white matter hyperintensities.
    Arola A; Laakso HM; Pitkänen J; Koikkalainen J; Lötjönen J; Korvenoja A; Erkinjuntti T; Melkas S; Jokinen H
    Eur J Neurol; 2021 Aug; 28(8):2622-2630. PubMed ID: 33977580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.
    Jokinen H; Koikkalainen J; Laakso HM; Melkas S; Nieminen T; Brander A; Korvenoja A; Rueckert D; Barkhof F; Scheltens P; Schmidt R; Fazekas F; Madureira S; Verdelho A; Wallin A; Wahlund LO; Waldemar G; Chabriat H; Hennerici M; O'Brien J; Inzitari D; Lötjönen J; Pantoni L; Erkinjuntti T
    Stroke; 2020 Jan; 51(1):170-178. PubMed ID: 31699021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural network changes in cerebral small vessel disease.
    Tuladhar AM; Tay J; van Leijsen E; Lawrence AJ; van Uden IWM; Bergkamp M; van der Holst E; Kessels RPC; Norris D; Markus HS; De Leeuw FE
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):196-203. PubMed ID: 31744851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment.
    Ogama N; Endo H; Satake S; Niida S; Arai H; Sakurai T
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2045-2055. PubMed ID: 34585518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease.
    Jokinen H; Melkas S; Madureira S; Verdelho A; Ferro JM; Fazekas F; Schmidt R; Scheltens P; Barkhof F; Wardlaw JM; Inzitari D; Pantoni L; Erkinjuntti T
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1296-1302. PubMed ID: 27951523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic cerebral small vessel disease and cognitive decline in healthy older adults: A systematic review and meta-analysis.
    Jansma A; de Bresser J; Schoones JW; van Heemst D; Akintola AA
    J Cereb Blood Flow Metab; 2024 May; 44(5):660-679. PubMed ID: 38415688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.